Showing results (11-20 of 10,176) with videos related to
Sort By:
Pageof 1,018
Cancer Biology & Medicine|December 9, 2024
Osimertinib exacerbates immune checkpoint inhibitor-related severe adverse events by activating the IL-6/JAK/STAT3 pathway in macrophagesYuan Li, Yanping Chen, Yuan Meng, et al.Journal of Leukocyte Biology|May 2, 2022
Relationship and prognostic significance of IL-33, PD-1/PD-L1, and tertiary lymphoid structures in cervical cancerYing Zhang, Jing Li, Fan Yang, et al.Thoracic Cancer|November 5, 2020
Autologous cytokine-induced killer (CIK) cells enhance the clinical response to PD-1 blocking antibodies in patients with advanced non-small cell lung cancer: A preliminary studyYing Han, Di Mu, Ting Liu, et al.Advances in Experimental Medicine and Biology|June 1, 2016
Adoptive Cellular Therapy (ACT) for Cancer TreatmentFan Yang, Hao Jin, Jian Wang, et al.Oncotarget|May 26, 2016
Soluble Toll-like receptor 4 is a potential serum biomarker in non-small cell lung cancerFeng Wei, Fan Yang, Jing Li, et al.Journal of Leukocyte Biology|January 18, 2024
Examining the spatial distribution of tumor-infiltrating immune cells in patients with stage I to IIIA LUADWeijiao Du, Fan Yang, Zhenzhen Hui, et al.Cancer Letters|June 2, 2018
New insights into the biological impacts of immune cell-derived exosomes within the tumor environmentMeng Shen, Xiubao RenTumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 29, 2017
Highlights on immune checkpoint inhibitors in non-small cell lung cancerMeng Shen, Xiubao RenOncoimmunology|October 26, 2020
Significantly different immunological score in lung adenocarcinoma and squamous cell carcinoma and a proposal for a new immune staging systemZiqing Zeng, Fan Yang, Yunliang Wang, et al.Journal of Leukocyte Biology|September 8, 2022
The prognostic value of a 4-factor neoimmunologic score system in non-small cell lung cancerFan Yang, Ziqing Zeng, Yuan Li, et al.Pageof 1,018